Fielmann Group reports +15% sales growth to €2.3 billion and +23% profitability jump in FY2024. Market share gains in major geographies. Strong results in primary eyecare and hearing aids businesses ...
Evotec SE announces key progress in neuroscience collaboration with Bristol Myers Squibb, receiving a $20 million payment for neurodegeneration research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback